There is increasing evidence that PPARγ was involved in AGEs-related disease, including diabetes and diabetes-related complications[20,21,22,23,24,25], cardiovascular disease[26], non-alcoholic fatty liver disease (NAFLD)[27], cognitive dysfunction and dementia[28], and OA[5,10]. This evidence concerns the gene PPARG and dementia.